Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTZ Paste vs ZOE Paste for Necrotic Primary Molars
NCT03650036Phase 2Completed
- Sponsor
- Universidade Federal do Piauí
- Start
- Jun 2018
- Primary completion
- May 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of chloramphenicol, tetracycline, zinc oxide and Eugenol in dental pulp necrosis (2 arms), sponsored by Universidade Federal do Piauí. Primary endpoints: Infection control of deciduous molars with necrotic pulp by clinical examination at 36 months and Infection control of deciduous molars with necrotic pulp by Radiographic examination at 36 months. Started Jun 2018; status: completed.
02
Drugs
chloramphenicoltetracyclinezinc oxideEugenol
03
Conditions
dental pulp necrosis
Beyond the preview
Go deeper on NCT03650036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03650036.